Presima Securities ULC lowered its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 16.5% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,009,181 shares of the real estate investment trust's stock after selling 198,841 shares during the quarter. Sabra Health Care REIT comprises approximately 4.1% of Presima Securities ULC's holdings, making the stock its 13th largest holding. Presima Securities ULC owned 0.43% of Sabra Health Care REIT worth $18,781,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Point72 Asset Management L.P. lifted its stake in Sabra Health Care REIT by 152.7% in the second quarter. Point72 Asset Management L.P. now owns 1,732,274 shares of the real estate investment trust's stock valued at $26,677,000 after buying an additional 1,046,748 shares during the period. Millennium Management LLC acquired a new stake in shares of Sabra Health Care REIT in the 2nd quarter valued at approximately $12,972,000. Vanguard Group Inc. boosted its stake in Sabra Health Care REIT by 2.5% during the 1st quarter. Vanguard Group Inc. now owns 34,972,611 shares of the real estate investment trust's stock worth $516,545,000 after acquiring an additional 838,654 shares during the last quarter. APG Asset Management US Inc. grew its holdings in Sabra Health Care REIT by 28.9% during the second quarter. APG Asset Management US Inc. now owns 2,562,962 shares of the real estate investment trust's stock valued at $39,495,000 after purchasing an additional 575,000 shares during the period. Finally, Renaissance Technologies LLC increased its stake in Sabra Health Care REIT by 77.0% in the second quarter. Renaissance Technologies LLC now owns 1,287,279 shares of the real estate investment trust's stock valued at $19,824,000 after purchasing an additional 559,800 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors.
NASDAQ:SBRA opened at $18.43 on Thursday. The stock has a 50-day simple moving average of $17.59 and a 200 day simple moving average of $15.79. Sabra Health Care REIT, Inc. has a 52-week low of $12.83 and a 52-week high of $19.32. The company has a market cap of $4.27 billion, a PE ratio of 92.15, a PEG ratio of 2.55 and a beta of 1.26. The company has a debt-to-equity ratio of 0.89, a quick ratio of 4.27 and a current ratio of 4.27.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The real estate investment trust reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.34 by ($0.24). The business had revenue of $176.14 million for the quarter, compared to the consensus estimate of $166.54 million. Sabra Health Care REIT had a return on equity of 1.87% and a net margin of 7.83%. Sabra Health Care REIT's revenue was up 9.3% compared to the same quarter last year. During the same period in the prior year, the business earned $0.34 earnings per share. On average, sell-side analysts expect that Sabra Health Care REIT, Inc. will post 1.38 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 19th were given a dividend of $0.30 per share. The ex-dividend date was Monday, August 19th. This represents a $1.20 annualized dividend and a yield of 6.51%. Sabra Health Care REIT's dividend payout ratio (DPR) is presently 600.00%.
A number of equities analysts have recently weighed in on SBRA shares. Scotiabank lifted their price target on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "sector perform" rating in a research report on Friday, October 11th. Truist Financial boosted their target price on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a "buy" rating in a research note on Wednesday, September 4th. Wells Fargo & Company raised Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and raised their price target for the stock from $16.00 to $20.00 in a research report on Tuesday, October 1st. Finally, Citigroup upgraded Sabra Health Care REIT from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $17.00 to $20.00 in a research report on Friday, September 13th. Two equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, Sabra Health Care REIT has a consensus rating of "Moderate Buy" and an average price target of $18.11.
Get Our Latest Stock Analysis on SBRA
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.